Why is Infinium Pharma falling/rising?

As of 17-Sep, Infinium Pharmachem Ltd's stock price is currently at 256.00, reflecting an increase of 3.0, or 1.19%. The stock has shown a mixed performance in recent periods, with a slight decline of 0.10% over the past week, but a positive return of 1.33% over the last month. Despite today's performance, which outperformed the sector by 1.15%, the stock is trading lower than its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a potential struggle in maintaining upward momentum. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 70.59% against the 5-day average, which may suggest waning interest among investors.
Broader market context indicates that while Infinium Pharmachem has experienced a year-to-date decline of 14.64%, the benchmark Sensex has gained 7.13% in the same timeframe. This underperformance relative to the benchmark highlights the challenges faced by the stock. Over the past month, the stock's return is notably lower than the Sensex's gain of 2.84%, further emphasizing the stock's struggle to attract investor confidence in a rising market. Overall, the combination of lower trading volumes and underperformance against the benchmark suggests that Infinium Pharmachem is facing headwinds that may be affecting its stock price movement.